TY  - GEN
AU  - Kapitza,C
AU  - Heise,T
AU  - Birman,P
AU  - Jallet,K
AU  - Ramis,J
AU  - Balena,R
TI  - Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes
SN  - 1464-5491
PY  - 2010///0729
KW  - Delayed-Action Preparations
KW  - administration & dosage
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Glucagon-Like Peptide 1
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - Peptides
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1464-5491.2009.02854.x
ER  -